Search results
This guideline was developed before the COVID-19 pandemic. It covers diagnosing and managing pneumonia in adults who do not have COVID-19. It aims to improve accurate assessment and diagnosis of pneumonia to help guide antibiotic prescribing and ensure that people receive the right treatment.
14 sie 2018 · Knowledge of local bacterial pathogens and their antibiotic susceptibility and resistance profiles is the key for effective pharmacologic selection and treatment of pneumonia.
14 lip 2016 · These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare ...
We endorse the empiric treatment recommendations for MRSA and P. aeruginosa provided by the 2016 Clinical Practice Guideline from IDSA and ATS for the management of adults with hospital-acquired and ventilator-associated pneumonia .
It aims to improve accurate assessment and diagnosis of pneumonia to help guide antibiotic prescribing and ensure that people receive the right treatment. For recommendations on managing suspected or confirmed pneumonia in adults with COVID-19, see NICE's guideline on managing COVID-19.
1 paź 2019 · This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia.
The following interventions have been shown to be successful in reducing pneumonia mortality: vaccination, including use of vaccines against infection by Streptococcus pneumoniae Haemophilus influenzae type b. case management of pneumonia in the community, health centres and hospitals.
